Review



polyclonal goat anti human tarc antibody  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 91
      Buy from Supplier

    Structured Review

    R&D Systems polyclonal goat anti human tarc antibody
    Figure 1. A–C, cHL with multiple HRS cells that are CD30-positive (B). <t>TARC</t> IHC in this case shows strong cytoplasmic staining in all the tumour cells (C). D–F, EBV-positive cHL with HRS cells that show diffuse CD30 positivity (E). TARC IHC shows a weak and incomplete stain- ing pattern (F). G–I, Nodular lymphocyte predominant Hodgkin lymphoma with CD20-positive tumour cells (H). TARC IHC in this case is completely negative in all tumour cells (I). cHL, classic Hodgkin lymphoma; HRS, Hodgkin/Reed–Sternberg; IHC, immunohistochemistry; TARC, thymus and activation-related chemokine.
    Polyclonal Goat Anti Human Tarc Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/polyclonal+goat-anti-human+tarc+antibody/Human+Survivin+Affinity+Purified+Polyclonal+Ab/pm36345263-35-32-38
    Average 91 stars, based on 7 article reviews
    polyclonal goat anti human tarc antibody - by Bioz Stars, 2026-10
    91/100 stars

    Images

    1) Product Images from "The value of thymus and activation related chemokine immunohistochemistry in classic Hodgkin lymphoma diagnostics."

    Article Title: The value of thymus and activation related chemokine immunohistochemistry in classic Hodgkin lymphoma diagnostics.

    Journal: Histopathology

    doi: 10.1111/his.14836

    Figure 1. A–C, cHL with multiple HRS cells that are CD30-positive (B). TARC IHC in this case shows strong cytoplasmic staining in all the tumour cells (C). D–F, EBV-positive cHL with HRS cells that show diffuse CD30 positivity (E). TARC IHC shows a weak and incomplete stain- ing pattern (F). G–I, Nodular lymphocyte predominant Hodgkin lymphoma with CD20-positive tumour cells (H). TARC IHC in this case is completely negative in all tumour cells (I). cHL, classic Hodgkin lymphoma; HRS, Hodgkin/Reed–Sternberg; IHC, immunohistochemistry; TARC, thymus and activation-related chemokine.
    Figure Legend Snippet: Figure 1. A–C, cHL with multiple HRS cells that are CD30-positive (B). TARC IHC in this case shows strong cytoplasmic staining in all the tumour cells (C). D–F, EBV-positive cHL with HRS cells that show diffuse CD30 positivity (E). TARC IHC shows a weak and incomplete stain- ing pattern (F). G–I, Nodular lymphocyte predominant Hodgkin lymphoma with CD20-positive tumour cells (H). TARC IHC in this case is completely negative in all tumour cells (I). cHL, classic Hodgkin lymphoma; HRS, Hodgkin/Reed–Sternberg; IHC, immunohistochemistry; TARC, thymus and activation-related chemokine.

    Techniques Used: Staining, Immunohistochemistry, Activation Assay

    Figure 2. A, B, reactive lymphadenopathy with multiple CD30-positive immunoblastic cells. TARC proved to be completely negative (B). C, D, Follicular lymphoma with numerous CD30-positive large B cell blasts (C). TARC IHC shows variable staining in part of the blasts (D). E, F, B cell lymphoma unclassifiable with features intermediate between diffuse large B cell lymphoma and classic Hodgkin lymphoma. TARC IHC is weakly positive in part of the tumour cells; the remainder is negative (F). G, H, primary mediastinal B cell lymphoma. TARC IHC shows a weak/variable staining with clear negativity of part of the tumour cells (H). IHC, immunohistochemistry; TARC, thymus and activation-related chemokine.
    Figure Legend Snippet: Figure 2. A, B, reactive lymphadenopathy with multiple CD30-positive immunoblastic cells. TARC proved to be completely negative (B). C, D, Follicular lymphoma with numerous CD30-positive large B cell blasts (C). TARC IHC shows variable staining in part of the blasts (D). E, F, B cell lymphoma unclassifiable with features intermediate between diffuse large B cell lymphoma and classic Hodgkin lymphoma. TARC IHC is weakly positive in part of the tumour cells; the remainder is negative (F). G, H, primary mediastinal B cell lymphoma. TARC IHC shows a weak/variable staining with clear negativity of part of the tumour cells (H). IHC, immunohistochemistry; TARC, thymus and activation-related chemokine.

    Techniques Used: Staining, Immunohistochemistry, Activation Assay

    Related Articles

    other:

    Article Title: P009 (0069) CD2 IS AN IMPORTANT ADHESION MOLECULE IN THE INITIAL INTERACTION BETWEEN HODGKIN REED-STERNBERG CELLS AND ROSETTING T CELLS
    Article Snippet: Briefly, after heat induce antigen retrieval (Ultra CC1), slides were incubated with a polyclonal goat-anti-human TARC antibody (1:800, R&D Systems, Minneapolis, MN) in an automated stainer (Ventana Benchmark).



    Similar Products

    polyclonal goat anti human tarc antibody  (R&D Systems)
    91
    R&D Systems polyclonal goat anti human tarc antibody
    Figure 1. A–C, cHL with multiple HRS cells that are CD30-positive (B). <t>TARC</t> IHC in this case shows strong cytoplasmic staining in all the tumour cells (C). D–F, EBV-positive cHL with HRS cells that show diffuse CD30 positivity (E). TARC IHC shows a weak and incomplete stain- ing pattern (F). G–I, Nodular lymphocyte predominant Hodgkin lymphoma with CD20-positive tumour cells (H). TARC IHC in this case is completely negative in all tumour cells (I). cHL, classic Hodgkin lymphoma; HRS, Hodgkin/Reed–Sternberg; IHC, immunohistochemistry; TARC, thymus and activation-related chemokine.
    Polyclonal Goat Anti Human Tarc Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/polyclonal+goat-anti-human+tarc+antibody/Human+Survivin+Affinity+Purified+Polyclonal+Ab/pm36345263-35-32-38
    Average 91 stars, based on 1 article reviews
    polyclonal goat anti human tarc antibody - by Bioz Stars, 2026-10
    91/100 stars
    		  Buy from Supplier
    goat polyclonal anti human tarc ccl17  (R&D Systems)
    90
    R&D Systems goat polyclonal anti human tarc ccl17
    Figure 1. A–C, cHL with multiple HRS cells that are CD30-positive (B). <t>TARC</t> IHC in this case shows strong cytoplasmic staining in all the tumour cells (C). D–F, EBV-positive cHL with HRS cells that show diffuse CD30 positivity (E). TARC IHC shows a weak and incomplete stain- ing pattern (F). G–I, Nodular lymphocyte predominant Hodgkin lymphoma with CD20-positive tumour cells (H). TARC IHC in this case is completely negative in all tumour cells (I). cHL, classic Hodgkin lymphoma; HRS, Hodgkin/Reed–Sternberg; IHC, immunohistochemistry; TARC, thymus and activation-related chemokine.
    Goat Polyclonal Anti Human Tarc Ccl17, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/polyclonal+goat-anti-human+tarc+antibody/Human+CCL17%2FTARC+Antibody/pm30953706-64-5-9
    Average 90 stars, based on 1 article reviews
    goat polyclonal anti human tarc ccl17 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    biotinylated goat anti human tarc polyclonal  (R&D Systems)
    90
    R&D Systems biotinylated goat anti human tarc polyclonal
    Fig. 1 Different types of immunoelectrophoresis of cat hair extract (Fel d) using a <t>polyclonal</t> rabbit antibody raised against the same extract (a Fel d). (a) CIE of Fel d extract, (b) FRIE following a purification (immunoab- sorption) of the major allergen Fel d 1, (c) CIE of purified Fel d 1 against a Fel d, (d) CLIE with Fel d 1 in inter- mediate gel for identification of the allergen, (e) TCIE with Fel d extract and Fel d 1 showing a double peak, (f) CIIE with monospecific Fel d 1 in intermediate gel
    Biotinylated Goat Anti Human Tarc Polyclonal, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/polyclonal+goat-anti-human+tarc+antibody/Human+CCL17%2FTARC+Biotinylated+Antibody/10__1007_slash_978___1___4939___9591___2-1871-1-6
    Average 90 stars, based on 1 article reviews
    biotinylated goat anti human tarc polyclonal - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    polyclonal goat-anti-human tarc antibody  (R&D Systems)
    90
    R&D Systems polyclonal goat-anti-human tarc antibody
    Fig. 1 Different types of immunoelectrophoresis of cat hair extract (Fel d) using a <t>polyclonal</t> rabbit antibody raised against the same extract (a Fel d). (a) CIE of Fel d extract, (b) FRIE following a purification (immunoab- sorption) of the major allergen Fel d 1, (c) CIE of purified Fel d 1 against a Fel d, (d) CLIE with Fel d 1 in inter- mediate gel for identification of the allergen, (e) TCIE with Fel d extract and Fel d 1 showing a double peak, (f) CIIE with monospecific Fel d 1 in intermediate gel
    Polyclonal Goat Anti Human Tarc Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/polyclonal+goat-anti-human+tarc+antibody/polyclonal+goat+anti+human+tarc/10__1097_slash_01__hs9__0000547861__04632__0a-5-13-18
    Average 90 stars, based on 1 article reviews
    polyclonal goat-anti-human tarc antibody - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    goat polyclonal anti human ccl17 ab  (R&D Systems)
    90
    R&D Systems goat polyclonal anti human ccl17 ab
    Immunohistochemical staining for conventional EMPD ( A , C , E ) and ectopic EMPD ( B , D , F ). Paraffin-embedded tissue samples were deparaffinized and stained with <t>anti-CCL17</t> Ab ( A , B ), anti-CCL5 Ab ( C , D ), and anti-MMP25 Ab ( E , F ). The sections were developed with liquid permanent red. Original magnification. ×200 ( A , B , D ), ×100 ( C ).
    Goat Polyclonal Anti Human Ccl17 Ab, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/polyclonal+goat-anti-human+tarc+antibody/Human+CCL17%2FTARC+Antibody/pmc04943311-21-49-54
    Average 90 stars, based on 1 article reviews
    goat polyclonal anti human ccl17 ab - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Figure 1. A–C, cHL with multiple HRS cells that are CD30-positive (B). TARC IHC in this case shows strong cytoplasmic staining in all the tumour cells (C). D–F, EBV-positive cHL with HRS cells that show diffuse CD30 positivity (E). TARC IHC shows a weak and incomplete stain- ing pattern (F). G–I, Nodular lymphocyte predominant Hodgkin lymphoma with CD20-positive tumour cells (H). TARC IHC in this case is completely negative in all tumour cells (I). cHL, classic Hodgkin lymphoma; HRS, Hodgkin/Reed–Sternberg; IHC, immunohistochemistry; TARC, thymus and activation-related chemokine.

    Journal: Histopathology

    Article Title: The value of thymus and activation related chemokine immunohistochemistry in classic Hodgkin lymphoma diagnostics.

    doi: 10.1111/his.14836

    Figure Lengend Snippet: Figure 1. A–C, cHL with multiple HRS cells that are CD30-positive (B). TARC IHC in this case shows strong cytoplasmic staining in all the tumour cells (C). D–F, EBV-positive cHL with HRS cells that show diffuse CD30 positivity (E). TARC IHC shows a weak and incomplete stain- ing pattern (F). G–I, Nodular lymphocyte predominant Hodgkin lymphoma with CD20-positive tumour cells (H). TARC IHC in this case is completely negative in all tumour cells (I). cHL, classic Hodgkin lymphoma; HRS, Hodgkin/Reed–Sternberg; IHC, immunohistochemistry; TARC, thymus and activation-related chemokine.

    Article Snippet: T A R C I M M U N O H I S T O C H E M I S T R Y Paraffin tissue sections (3 lm) were incubated with polyclonal goat anti-human TARC antibody (1:800; R&D Systems, Minneapolis, MN, USA) on the automated Benchmark ULTRA platform (Ultra CC1, 52 min; Roche, Ventana Medical Systems, Oro Valley, AZ, USA).

    Techniques: Staining, Immunohistochemistry, Activation Assay

    Figure 2. A, B, reactive lymphadenopathy with multiple CD30-positive immunoblastic cells. TARC proved to be completely negative (B). C, D, Follicular lymphoma with numerous CD30-positive large B cell blasts (C). TARC IHC shows variable staining in part of the blasts (D). E, F, B cell lymphoma unclassifiable with features intermediate between diffuse large B cell lymphoma and classic Hodgkin lymphoma. TARC IHC is weakly positive in part of the tumour cells; the remainder is negative (F). G, H, primary mediastinal B cell lymphoma. TARC IHC shows a weak/variable staining with clear negativity of part of the tumour cells (H). IHC, immunohistochemistry; TARC, thymus and activation-related chemokine.

    Journal: Histopathology

    Article Title: The value of thymus and activation related chemokine immunohistochemistry in classic Hodgkin lymphoma diagnostics.

    doi: 10.1111/his.14836

    Figure Lengend Snippet: Figure 2. A, B, reactive lymphadenopathy with multiple CD30-positive immunoblastic cells. TARC proved to be completely negative (B). C, D, Follicular lymphoma with numerous CD30-positive large B cell blasts (C). TARC IHC shows variable staining in part of the blasts (D). E, F, B cell lymphoma unclassifiable with features intermediate between diffuse large B cell lymphoma and classic Hodgkin lymphoma. TARC IHC is weakly positive in part of the tumour cells; the remainder is negative (F). G, H, primary mediastinal B cell lymphoma. TARC IHC shows a weak/variable staining with clear negativity of part of the tumour cells (H). IHC, immunohistochemistry; TARC, thymus and activation-related chemokine.

    Article Snippet: T A R C I M M U N O H I S T O C H E M I S T R Y Paraffin tissue sections (3 lm) were incubated with polyclonal goat anti-human TARC antibody (1:800; R&D Systems, Minneapolis, MN, USA) on the automated Benchmark ULTRA platform (Ultra CC1, 52 min; Roche, Ventana Medical Systems, Oro Valley, AZ, USA).

    Techniques: Staining, Immunohistochemistry, Activation Assay

    Fig. 1 Different types of immunoelectrophoresis of cat hair extract (Fel d) using a polyclonal rabbit antibody raised against the same extract (a Fel d). (a) CIE of Fel d extract, (b) FRIE following a purification (immunoab- sorption) of the major allergen Fel d 1, (c) CIE of purified Fel d 1 against a Fel d, (d) CLIE with Fel d 1 in inter- mediate gel for identification of the allergen, (e) TCIE with Fel d extract and Fel d 1 showing a double peak, (f) CIIE with monospecific Fel d 1 in intermediate gel

    Journal: Methods in Molecular Biology

    Article Title: Allergy

    doi: 10.1007/978-1-4939-9591-2

    Figure Lengend Snippet: Fig. 1 Different types of immunoelectrophoresis of cat hair extract (Fel d) using a polyclonal rabbit antibody raised against the same extract (a Fel d). (a) CIE of Fel d extract, (b) FRIE following a purification (immunoab- sorption) of the major allergen Fel d 1, (c) CIE of purified Fel d 1 against a Fel d, (d) CLIE with Fel d 1 in inter- mediate gel for identification of the allergen, (e) TCIE with Fel d extract and Fel d 1 showing a double peak, (f) CIIE with monospecific Fel d 1 in intermediate gel

    Article Snippet: Detection: Biotinylated goat anti-human TARC polyclonal (R&D Systems #BAF364 or PeproTech).

    Techniques: Immunoelectrophoresis, Purification

    Immunohistochemical staining for conventional EMPD ( A , C , E ) and ectopic EMPD ( B , D , F ). Paraffin-embedded tissue samples were deparaffinized and stained with anti-CCL17 Ab ( A , B ), anti-CCL5 Ab ( C , D ), and anti-MMP25 Ab ( E , F ). The sections were developed with liquid permanent red. Original magnification. ×200 ( A , B , D ), ×100 ( C ).

    Journal: Case Reports in Dermatology

    Article Title: RANKL-Expressing Ectopic Extramammary Paget's Disease on the Lower Abdomen

    doi: 10.1159/000445992

    Figure Lengend Snippet: Immunohistochemical staining for conventional EMPD ( A , C , E ) and ectopic EMPD ( B , D , F ). Paraffin-embedded tissue samples were deparaffinized and stained with anti-CCL17 Ab ( A , B ), anti-CCL5 Ab ( C , D ), and anti-MMP25 Ab ( E , F ). The sections were developed with liquid permanent red. Original magnification. ×200 ( A , B , D ), ×100 ( C ).

    Article Snippet: The following antibodies (Abs) were used for immunofluorescence staining: mouse monoclonal anti-human CD163 Ab (clone: 10D6; Novocastra, UK), and anti-human CCL5 Ab (clone: 50013–5; LifeSpan BioScience, Seattle, Wash., USA), rabbit polyclonal anti-human RANKL Ab (LifeSpan BioScience), anti-human MMP7 Ab (LifeSpan BioScience), and anti-human MMP25 Ab (Abcam, Tokyo, Japan), and goat polyclonal anti-human CCL17 Ab (R&D Systems, Tokyo, Japan).

    Techniques: Immunohistochemical staining, Staining